本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

32.78
+1.073.37%
盘后33.110.3300+1.01%19:14 EDT
成交量:189.03万
成交额:6,205.88万
市值:52.17亿
市盈率:-10.94
高:33.20
开:32.25
低:32.01
收:31.71
数据加载中...
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/09

重要事件披露

Form 8-K - Current report
2024/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities